RxDoctor Payments Data

Sandeep Jain

Clinical Cardiac Electrophysiology · Pittsburgh, PANPI 1003880444

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (33.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 72.7% of it on its own, with 11 other manufacturers making up the rest.

$30,486in general payments, 2019–2025

Across 157 payments — averaging $194.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$22K
  • Boston Scientific$3K
  • Medtronic$3K
  • Atricure, Inc.$904
  • Impulse Dynamics (USA) Inc.$860
  • Biosense Webster, Inc.$197
  • plus $280 from 6 others
$1,285,099in research payments, 2019–2025

Across 411 payments — averaging $3126.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$545K
  • Medtronic$524K
  • Abbott$203K
  • Impulse Dynamics (USA) Inc.$13K

What the payments were for

  • Consulting fees$5,00016%
  • Speaking & faculty fees$10,17533%
  • Grants$1470%
  • Travel & lodging$5,93819%
  • Food & beverage$9,22630%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,486 in reported general payments places this provider in the 65th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$129,548
Medicare patients
689
Services billed
1,351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban546$615,838
XareltoRivaroxaban166$178,469
Dofetilide540$148,162
MultaqDronedarone Hcl46$53,805
Metoprolol Succinate416$6,460
Mexiletine Hcl55$5,135
SotalolSotalol Hcl231$5,011
Flecainide Acetate112$4,172
Diltiazem 24hr Er (Cd)Diltiazem Hcl141$2,834
Amiodarone Hcl134$2,620
Metoprolol Tartrate161$1,499
Carvedilol53$789
Digoxin33$590
Cartia XtDiltiazem Hcl20$402
Atenolol29$207

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →